HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.
Management will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.
The board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.
Comments